Ceradyne (CRDN) announced that its preliminary sales figure for 2009 is approximately $401 million. These full year preliminary results compare to the guidance given on October 27, 2009 of sales in a range of $410 million to $415 million. The company noted that full year earnings are estimated to meet or slightly exceed the current guidance of approximately $0.60 per share which do not include the impact of restructuring and impairment charges for all of 2009 of approximately $0.55 per share.
Further, the company reiterated its 2010 guidance, initially provided on October 27, 2009, of a sales range of $380 million to $430 million and an earnings range of $0.60 to $1.05 per share.
Analysts expect the company to report earnings of $0.75 per share, on revenues of $391.01 million. Analysts' estimates typically exclude special items.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.